Dose awareness extends to nuclear medicine exams with the development of online materials to guide providers on radiopharmaceutical dose utilization.
Dose awareness is being extended to nuclear medicine exams with the development of online materials to guide providers on radiopharmaceutical dose utilization.
Image Wisely, the Society of Nuclear Medicine and Molecular Imaging, the SNMMI Technologist Section and the American Society of Nuclear Cardiology are collaborating to provide materials for physicians, medical physicists, and technologists. The materials are available at ImageWisely.org.
“Nuclear medicine exams help save and extend lives every day, but opportunities remain to ensure that each patient receives optimal care,” M. Elizabeth Oates, MD, chair of the American College of Radiology Nuclear Medicine Commission, said in a statement.
The nuclear medicine initiative urges providers to:
Providers can demonstrate their commitment to the cause by earning accreditation from the ACR or equivalent organization and by taking the Image Wisely pledge as an individual, facility or association.
“Radiation dose for all nuclear medicine and molecular imaging procedures should be
optimized so that the patient receives the smallest possible amount of radiopharmaceutical
that will provide the appropriate diagnostic information,” Frederic H. Fahey, DSc, FACR, FAAPM, SNMMI president and representative to Image Wisely, said in a statement.
Image Wisely is a collaborative initiative of the ACR, the Radiological Society of North America, ASRT and AAPM.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.